Get started
Author

Maimah Karmo

ORCID: 0000-0002-5500-977X
Observed ORCID: 0000-0002-5500-977X
OpenAlex ID: A5015265782
Interventions to reduce cancer screening inequities: the perspective and role of patients, advocacy groups, and empowerment organizations
2023 · Afua Richardson-Parry, Carole Baas, et al. · International Journal for Equity in Health · 56
PDF
The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator
2022 · Andrea Anampa-Guzmán, Janet Freeman-Daily, et al. · JCO Oncology Practice · 39
INAVO122: A phase III study of maintenance inavolisib or placebo + pertuzumab + trastuzumab following induction with pertuzumab + trastuzumab + a taxane in patients (pts) with PIK3CA-mutated, HER2-positive advanced breast cancer (HER2+ aBC).
2024 · Sandra M. Swain, Carlos H. Barrios, et al. · Journal of Clinical Oncology · 11
A Framework to Promote Implementation of Patient-Reported Outcomes in Institutions Caring for Vulnerable and Underserved Cancer Populations
2024 · Anne L. R. Schuster, Norah L. Crossnohere, et al. · Patient · 4
PDF
Engaging Patient Advocates to Reduce Breast Cancer Disparities: Opportunities to Advance Breast Cancer Research and Engagement
2025 · Megan C. Edmonds, Maimah Karmo, et al. · Journal of Cancer Education · 2
PDF
Social Media and the Quest for Equity and Diversity in Oncology: On Safe Spaces and the Concept of the Public Physician
2022 · Narjust Florez, Maimah Karmo, et al. · JCO Oncology Practice · 2
Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity Transformation
2022 · Maimah Karmo, Amy Pierre, MSN, ANP-BC · Journal of the Advanced Practitioner in Oncology · 2
Abstract B063: A community-based organization, health equity uplift and growth alliance for triple negative breast cancer and metastatic breast cancer in young women
2024 · Jeanne M. Regnante, Mandi L. Pratt-Chapman, et al. · Cancer Epidemiology Biomarkers & Prevention · 1
The case for acceleration of prospective multi- stakeholder led community-based research in young Black women with triple negative breast cancer (TNBC).
2023 · Jeanne Regnante, Mandi L. Pratt-Chapman, et al. · Journal of Clinical Oncology · 1
PDF
Abstract PO-084: The pharmaceutical industry in action: 2021 clinical research diversity and inclusion survey
2022 · Jeanne M. Regnante, Lola Fashoyin-Aje, et al. · Cancer Epidemiology Biomarkers & Prevention · 1
Unlocking the Conversation: Navigating ESR1 Mutations in Metastatic Breast Cancer
2025 · Maimah Karmo, Nicole A. Colwell, et al. · Oncology Issues
Abstract B120: A call for a modernized TNBC/mTNBC clinical trial: Ensuring equity, precision medicine, and survivorship for young Black women
2025 · Jeanne M. Regnante, Nicole Simone, et al. · Cancer Epidemiology Biomarkers & Prevention
Learning from Black patients with TNBC to implement equitable cancer care.
2024 · Virginia Leach, Jeanne Regnante, et al. · Journal of Clinical Oncology
Abstract PO3-16-07: Strategies to Enact for Equitable and Unbiased Care of Black, Triple Negative Breast Cancer Patients
2024 · Virginia Leach, Jeanne Regnante, et al. · Cancer Research
Patients Drive Authentic Trusted Solutions for Inclusive Clinical Trials
2024 · Maimah Karmo, Katherine Cornish, et al. · Current Breast Cancer Reports
Abstract A034: How we learn from Black TNBC patients to act for equitable and unbiased care
2023 · Virginia Leach, Jeanne Regante, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract A033: Use of a novel healthtech platform to record patient-reported needs in real time
2023 · Katherine Cornish, Mary Stober Murray, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract PO-033: 'Pull Up A Seat': A program shining a light on the experiences of Black women with breast cancer for healthcare providers and the scientific community
2020 · Julia Maues, Maimah Karmo, et al. · Cancer Epidemiology Biomarkers & Prevention
Works count: 18
Citation count: 119
H-index: 4
I10-index: 3
Year
Topic
Type